A PSA of 127 indicated a high probability of prostate cancer, leading to immediate Lupron ADT therapy and radiation treatment ...

ASCO GU 2025 had groundbreaking advancements in genitourinary cancer treatments, focusing on prostate cancer, renal cell ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

Pre-biopsy MRIs can help doctors diagnose and treat prostate cancer more accurately. Here’s when you should get one.

Facing a prostate cancer diagnosis can feel overwhelming, but you don’t have to navigate it alone. When prostate cancer is caught early, there are several treatment options to consider, and in some ...

Prostate cancer and an enlarged prostate are not the same thing. (Getty Images) On Yahoo Search, searches around terms including "prostate cancer" have gone up about 150% since the royal's diagnosis ...

Shared insight on the value of multidisciplinary care and its current state in cardiovascular disease and prostate cancer. Bhavesh Shah, RPh, BCOP: In oncology, we’ve already seen cross-collaboration ...

For more than 80 years, men have been told that testosterone fuels prostate cancer. But a more nuanced picture has emerged ...

One in eight men in the United States will develop prostate cancer as they get older. It’s the most common cancer in men in this country besides skin cancer. Worldwide, it is second only to lung ...

Multidisciplinary care in prostate cancer involves urologic, radiation, and medical oncologists, optimizing treatment through a collaborative approach. Clinical trials may benefit patients with ...

Prostate cancer is the most common cancer diagnosis among U.S. veterans, who are twice as likely to be diagnosed than men in the general public. In fact, one in five U.S. veterans are at risk for ...

Cancer of the prostate has become the leading cause of cancer diagnoses among males in the United Kingdom. Its treatment, ...